Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report

[1]  P. Zamboni.  Regarding “No Cerebrocervical Venous Congestion in Patients with Multiple Sclerosis. Intraluminal Jugular Septation” , 2010, Annals of neurology.

[2]  J. Requarth.  Regarding "A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency". , 2010, Journal of vascular surgery.

[3]  F. Paul,et al.  No cerebrocervical venous congestion in patients with multiple sclerosis , 2010, Annals of neurology.

[4]  A. Wåhlin,et al.  Venous and cerebrospinal fluid flow in multiple sclerosis: A case‐control study , 2010, Annals of neurology.

[5]  R. Hohlfeld,et al.  ["Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients]. , 2010, Der Nervenarzt.

[6]  C. Krogias,et al.  „Chronische zerebrospinale venöse Insuffizienz“ und Multiple Sklerose , 2010, Der Nervenarzt.

[7]  F. Salvi,et al.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. , 2009, Journal of vascular surgery.

[8]  G. Johnson,et al.  White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis , 2009, Journal of the Neurological Sciences.

[9]  F. Salvi,et al.  The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. , 2009, Functional neurology.

[10]  Peter K Stys,et al.  Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis , 2009, The Lancet Neurology.

[11]  F. Salvi,et al.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[12]  J. De Keyser,et al.  Hypoperfusion of the Cerebral White Matter in Multiple Sclerosis: Possible Mechanisms and Pathophysiological Significance , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  Robert Zivadinov,et al.  Application of hidden Markov random field approach for quantification of perfusion/diffusion mismatch in acute ischemic stroke , 2008, Neurological research.

[14]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[15]  M. Ramanathan,et al.  Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. , 2007, Human molecular genetics.

[16]  F. Paul,et al.  Cerebral blood perfusion changes in multiple sclerosis , 2007, Journal of the Neurological Sciences.

[17]  Glyn Johnson,et al.  Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. , 2007, Archives of neurology.

[18]  Glyn Johnson,et al.  Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T , 2006, NeuroImage.

[19]  G. Schmid-Schönbein,et al.  Chronic venous disease. , 2006, Minerva cardioangiologica.

[20]  M. Kubo,et al.  Intracranial dural arteriovenous fistulas with retrograde cortical venous drainage: assessment with cerebral blood volume by dynamic susceptibility contrast magnetic resonance imaging. , 2006, AJNR. American journal of neuroradiology.

[21]  Glyn Johnson,et al.  Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. , 2005, AJNR. American journal of neuroradiology.

[22]  G. Johnson,et al.  Microvascular Abnormality in Relapsing-remitting Multiple Sclerosis: Perfusion Mr Imaging Findings in Normal-appearing White Matter , 2003 .

[23]  A. Fujita,et al.  Haemodynamic assessment in patients with dural arteriovenous fistulae: dynamic susceptibility contrast-enhanced MRI , 2002, Neuroradiology.

[24]  G. Calo’,et al.  Effects of vasoactive agents in healthy and diseased human saphenous veins. , 1998, Journal of vascular surgery.

[25]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[26]  B. Rosen,et al.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.

[27]  P. Zamboni,et al.  Diagnosis and treatment of venous malformations. Consensus document of the International Union of Phlebology (IUP)-2009. , 2009, International angiology : a journal of the International Union of Angiology.

[28]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[29]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .